"If the clinical trial goes well, the opportunities for the use of Xenon gas are great," said co-author Howard Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases at BWH and ...

Oleg Butovsky, PhD, senior and co-corresponding author of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital (BWH) "It is exciting that in both animal models that model ...

Scientists are constantly seeking new treatments for Alzheimer's disease. Most recently, researchers from Mass General Brigham and Washington University School of Medicine ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...

“If the clinical trial goes well, the opportunities for the use of xenon gas are great,” said co-author Howard Weiner, co-director of Ann Romney Center for Neurologic Diseases at Brigham and ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble ...

“If the clinical trial goes well, the opportunities for the use of Xenon gas are great,” said co-author Howard Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases at BWH ...

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...

Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury: New York Saturday, January 25, 2025, 13:00 Hrs [IST] Tizian ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...